|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3900 USD | -2.50% |
|
-2.50% | -13.33% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.75M 1.64M 3.07M 205M 3.1M 20.78M 8.07M 101M 8.16M 7.99M 350M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.75M 10.83M 10.19M 19.05M 1.27B 19.19M 129M 50.03M 626M 50.6M 49.52M 2.17B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -2.50% | ||
| 1 week | -2.50% | ||
| Current month | +5.41% | ||
| 1 month | -25.00% | ||
| 3 months | +11.43% | ||
| 6 months | +0.31% | ||
| Current year | -13.33% |
| 1 week | 0.39 |  | 0.39 |
| 1 month | 0.37 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.16 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.50% | -2.50% | +8.51% | -63.89% | 2.83M | |
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | |
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | |
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | |
| Average | -1.88% | -1.79% | +18.08% | +28.96% | 337.12B | |
| Weighted average by Cap. | -1.77% | -2.88% | +28.03% | +63.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.1M 18.53M 17.43M 32.61M 2.17B 32.84M 220M 85.62M 1.07B 86.6M 84.74M 3.71B | 24.22M 21.1M 19.45M 18.29M 34.22M 2.28B 34.47M 231M 89.86M 1.12B 90.89M 88.94M 3.9B |
| Net income | -5.27M -4.59M -4.23M -3.98M -7.44M -496M -7.5M -50.33M -19.55M -245M -19.77M -19.35M -848M | -3.2M -2.79M -2.57M -2.42M -4.53M -302M -4.56M -30.61M -11.89M -149M -12.02M -11.76M -516M |
| Net Debt | 10.2M 8.88M 8.19M 7.7M 14.41M 961M 14.51M 97.44M 37.84M 474M 38.27M 37.45M 1.64B | 11.31M 9.85M 9.08M 8.54M 15.98M 1.07B 16.09M 108M 41.96M 525M 42.44M 41.53M 1.82B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 0.3900 $ | -2.50% | 125 |
| 11/06/26 | 0.4000 $ | +2.56% | 3,999 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
